News

Liver cancer is still relatively rare in the United States, representing 2.1% of all new cancer diagnoses in 2025. The report ...
New research published Tuesday concludes that the rising rate of extreme childhood obesity—well above the usual BMI ...
GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver disease and type 2 diabetes ...
The Canadian researcher has just received the Frontiers of Knowledge Award for his work on anti-obesity drugs. However, he ...
The risks of the new weight-loss drugs can sound scary, and there’s lots of talk about side effects. What does evidence show?
First, a drug like Ozempic mimics the natural GLP-1 hormone in your gut, which slows down digestion in the stomach and ...
Endocrinologist Dr Ambrish Mithal, the author of the recently-released book, The Weight Loss Revolution, talks to fitness and ...
More than 40% of Americans are obese, according to the Centers for Disease Control and Prevention (CDC). And the epidemic isn ...
The hormonal changes of menopause can make the weight gain more resistant to traditional diet and lifestyle changes. But ...
Metformin is a safe, effective and cheap, and is showing it has promise for longevity, long Covid, weight control and other ...
Obesity is not a personal moral failing. It is a complex, multi-factorial condition driven by genetics, environment, and a ...
Dear J.H.: Metformin, a treatment for diabetes that works mostly by preventing the liver from making sugar, isn't new and has ...